MINOCYCLINE

SynDRA canonical compound SYN0006704 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	PARP1
Mechanism of action	bacterial 30S ribosomal subunit inhibitor \| ribosomal protein inhibitor
Indication	brucellosis \| chancroid \| cholera \| conjunctivitis \| fever \| psittacosis \| respiratory tract infections \| stroke \| trachoma \| tularemia \| urethritis
Disease area	endocrinology \| infectious disease \| neurology/psychiatry \| ophthalmology \| urology

All known targets

minocycline hydrochloride
minocycline HCl
Minociclina
Borymycin
MINO
MIY
Minociclinum
Minocin
Minocline
Minocyclin
Minocyclinum
Minocycline Monohydrochloride
CL 59806
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
Minociclina [INN-Spanish]
Minocin (Hydrochloride)
Minocin (TN)
Minocyclinum [INN-Latin]
Vectrin (Hydrochloride)
CRL-1605 & Minocycline
Minocycline (USAN/INN)
Minocycline [USAN:BAN:INN]
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
Dynacin
Minomycin
CL-59806
Minocyn
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE
CHEBI:50694
FYY3R43WGO
Tri-minocycline
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
NCGC00183044-01
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-